Technology

Pacira BioSciences

$69.82
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$3.53 (-4.81%) As of 4:00 PM UTC today

Why Robinhood?

You can buy or sell PCRX and other stocks, options, and ETFs commission-free!

About PCRX

Pacira Biosciences, Inc. develops and manufactures injectable therapeutic products. The firm engages in the development, commercialization and manufacture of pharmaceutical products for use in postsurgical outcomes for acute care practitioners and their patients. Its flagship product, EXPAREL, redefines pain management after surgery as an opioid-free alternative indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. The company was founded in December 2006 and is headquartered in Parsippany, NJ. The listed name for PCRX is Pacira BioSciences, Inc. Common Stock.

CEO
David M. Stack
Employees
606
Headquarters
Parsippany, New Jersey
Founded
2006
Market Cap
2.99B
Price-Earnings Ratio
26.00
Dividend Yield
Average Volume
720.73K
High Today
$71.73
Low Today
$68.86
Open Price
$71.61
Volume
195.65K
52 Week High
$77.89
52 Week Low
$27.46

Collections

PCRX Earnings

$0.00
$0.23
$0.45
$0.68
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 18, Pre-Market

You May Also Like

GIGB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure